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Pharmacological and biochemical activitiesStingrays from the Potamotrygon cf. henlei species are widely distributed in high numbers throughout the
rivers of central-west Brazil, being the source of numerous envenomations occurring in the dry season, posing
a serious public health problem even if not properly reported. The accidents usually involve ﬁshermen and
bathers, and to date there is no effective treatment for the injured. Considering these facts and limitations of
studies aiming at understanding the effects induced by P. cf. henlei envenoming, this study aimed to describe
the principal pharmacological and certain biochemical properties of the mucus and sting venom. We found
that mucus and sting venom is toxic to mice having nociceptive, edematogenic and proteolysis activities. Our
results also indicate that the inﬂammatory cellular inﬂux observed could be triggered by the venom and
mucus. Furthermore the venom and mucus were partially puriﬁed by solid-phase extraction tested for
antimicrobial activity in which only the mucus presented activity. It could be inferred from the present study
that P. cf. henlei venom possesses a diverse mixture of peptides, enzymes and pharmacologically active
components.oxinologia Aplicada Center for
venida Vital Brazil 1500, São
.
evier OA license.© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Venomous ﬁsh are diverse with representatives spread across four
orders, distributed worldwide but being largely concentrated in
tropical areas [1–4]. Their envenomation cause numerous reported
injuries with symptoms as intense pain, skin necrosis, blisters, ulcers,
fever, and rarely death probably associated with bacterial infections
[2,4–6]. Although accidents caused by these animals are considered
severe, it is surprising that only a few studies have ever examined this
relationship [7–9], given all the pharmaceutical beneﬁts and health
threats posed by venomous aquatic animals [10].
Stingrays are found in shallow tropical coasts worldwide to
temperate waters (including marine and freshwater species) [11–
14]. In South America, freshwater stingrays are included in the
Potamotrygonidae family, which comprise three valid genera: Plesio-
trygon, Paratrygon and Potamotrygon, the last being more diversiﬁed,
with 19 described species [15,16]. Freshwater stingrays in Brazil are
very common in northern, central-western and southeastern rivers,
and marine stingrays are distributed throughout the Atlantic Ocean
coast [16].Stingraysmayhaveone to seven spines on theirwhip-like tail,which
are responsible for numerous injuries worldwide [17–19]. Their spines
are hard, sharp, bilaterally retroserrated and covered by an integumen-
tary sheath with a ventrolateral glandular groove containing venom
glands along either edge [5]. The spine, called a venom apparatus, is
often covered with a ﬁlm of venom and mucus also covering the entire
body of these animals. Envenomation by stingrays is relatively common
amongﬁsherman, bathers and swimmers inwhich .injuriesmay be very
painful, causing complications such as nausea, vomiting, salivation,
sweating, respiratory depression, muscle fasciculation, convulsions,
edema, and ischemic necrosis [2,20–24].
In addition tovenom, the skin ofﬁshplays apassive role inprotective
immunity, serving as ananatomical andphysiological barrier against the
external environment. Skinmucus, secretedbymucous cells localized in
the epidermis, is considered theﬁrst lineof defense, as observed inother
ﬁsh species [25]. The mucus, such as that produced by the skin of the
stingrays, may include amino acids, peptides, complex carbohydrates,
glycopeptides, glycolipids and other chemicals [26]. The mucus is
known to comprise a number of immunecomponents suchas lysozyme,
immunoglobulin, complement, carbonic anhydrase, lectins, crinotoxins,
calmodulin, C-reactive protein, proteolytic enzymes and antimicrobial
peptides [27,28]. Therefore, the presence of one or several of these
compounds could increase the severity of injuries caused by freshwater
stingrays as presented by Magalhães et al. [14].
Despite that a wide variety of ﬁsh species have been described,
there is little information in the literature on stingray mucus. Most
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biological effects. In one study, our group [14] demonstrated that the
venom of Potamotrygon gr. orbignyi can induce edematogenic and
nociceptive responses, necrosis in mice as well as the presence of
enzymatic activity. This work leads us to a better and more detailed
study of this venom and its compounds, purifying toxins to allow
pharmacological investigations. By this approach, we isolated two
bioactive peptides from the venom of the P. gr orbignyi freshwater
stingray [29,30]. These peptides, called orpotrin and porﬂan, shown to
be effective in the microcirculatory environment, induce strong
vasoconstriction and inﬂammation, respectively. Caseinolytic, gelati-
nolytic and hyaluronidase activity was identiﬁed in Potamotrygon
falkneri venom [22]. Barbaro et al. [18], comparing extracts from tissue
of marine and freshwater stingrays Dasyatis guttata and Potamorygon
falkneri, observed edematogenic, gelatinolytic, caseinolytic and
ﬁbrinogenolytic activity in both extracts. Nociceptive activity was
veriﬁed in both tissue extracts; however, P. falkneri presented two-
fold greater activity than D. guttata. Lethal, dermonecrotic, myotoxic
and hyaluronidase activities were observed only in the tissue extract
of P. falkneri.
In central-west rivers of Brazil, there is a wide distribution of
stingrays from Potamotrygon cf. henlei stingray species, with the
highest incidence of envenoming occurring in the dry season,
resulting in a serious public health problem. The accidents usually
involve ﬁshermen and bathers, and presently, there is no effective
treatment for this injury. Considering these facts and limitations in
studies aiming at understanding the effects induced by P. cf. henlei
envenoming, this study aimed to describe the principal pharmaco-
logical and certain biochemical properties of the mucus and sting
venom from P. cf. henlei. Furthermorewe investigated the action of the
mucus collected near the sting and back of the animals.
2. Materials and methods
2.1. Animals
Groups of 5 Swiss mice weighing 18–22 g were used throughout
the study. The animals provided by the Instituto Butantan animal
house were kept in temperature and humidity-controlled rooms, and
received food and water ad libitum. All the procedures involving mice
were in accordance with the guidelines provided by the Brazilian
College of Animal Experimentation (number 730/10).
2.2. Venom and mucus
Specimens from adult female and male (n=15) P. cf. henlei ﬁsh
were collected from the Manoel Alves River in the state of Tocantins,
Brazil. Venom produced by venom glands (Vn) and mucus dispersed
throughout the spine were collected after scraping both the
epithelium and mucus, respectively. The mucus venom dispersed on
the dorsal area of the animal was collected and named ‘far’ (Mf) from
the sting and the mucus ‘near’ (Mn) was the mucus collected in the
region of the tail next to the sting. Both mucus and venom were
obtained by scraping the skin and sting with a glass slide, being
immediately stored on ice, and then diluted in sterile saline,
homogenized, and centrifuged for collection of the supernatant. The
sting venom extraction was done by scraping the sting. The
supernatant was collected and stored at −20 °C. Protein content
was determined by the method of Bradford [31] using bovine serum
albumin (Sigma Chemical Co., St Louis, MO) as standard protein.
2.3. Estimation of nociceptive activity
Nociceptive activity of the venom and mucus was assayed
according to the Hunskaar et al. [32]. Samples (Mucus near, Mucus
far and Venom) of 30 μl containing different doses of proteins (25, 50and 100 μg), were injected (i.pl.) in the right footpad of mice. The
control group was injected only with sterile PBS. Then, each mouse
was kept in an adapted chamber mounted on a mirror for 10 min.
Each animal was then returned to the observation chamber, and the
amount of time spent licking or biting each hind paw was recorded.
Each bar represents the mean±SEM.
2.4. Estimation of edema-inducing activity
Edematogenic activity was assayed according to the Lima et al.
[33]. Samples (Mucus near, Mucus far and Venom) of 30 μl containing
different doses of protein (25, 50 and 100 μg) were injected in the
right footpad of mice (i.pl.) and local edema was quantiﬁed 2 h after
injection. Additionally, mice were injected with 100 μg of venom or
different mucus, and edema was measured at 0.5, 1, 2, 3, 4 and 5 h
after injection. Mice injected with 30 μl of sterile PBS were considered
the control group. Local edema was quantiﬁed by measuring the
thickness of injected paws with a paquimeter (Mytutoyo Sul
Americana, SP, Brazil). Results were expressed by the difference
between experimental and control footpad thickness. Each bar
represents mean±SEM.
2.5. Evaluation of the vascular permeability
For permeability analysis, Evans blue dye, 20 mg/kg in 200 μl of
PBS was i.v. (intravenously) administered 20 min before i.p. (intra-
peritoneal) administration of the mucus near, mucus far and venom
(25, 50 and 100 μg) or PBS (control group). After 2 h, mice were
sacriﬁced, and their peritoneal cavities were washed with 2 ml of ice-
cold PBS and 0.1% bovine serum albumin (BSA). The cells were spun
down, and the optical density (OD) of the supernatant was measured
at 620 nm as an indicator of Evans blue leakage into the peritoneal
cavity [34]. The results were expressed in μg of Evans blue/ml, and the
concentration of Evans blue was calculated from a standard curve of a
known concentration.
2.6. Intravital microscopy
The dynamic of alterations in the microcirculatory network were
determined using intravital microscopy by transillumination of mice
cremaster muscle after subcutaneous application 100 μg of protein
venom or mucus of Potamotrygon cf. henlei dissolved in 20 μl of sterile
saline. Administration of the same amount of sterile salinewas used as
control. In three independent experiments (n=4), mice were
injected with 0.4% Xilazine (Coopazine®, Schering-Plough) and then
anaesthetizedwith 0.2 g/kg chloral hydrate, and the cremastermuscle
was exposed for microscopic examination in situ as described by Baez
[35] and Lomonte et al. [36]. The animals were maintained on a board
thermostatically controlled at 37 °C, which included a transparent
platform on which the tissue to be transilluminated was placed. After
the stabilization of the microcirculator, the number of roller cells and
adherent leukocytes in the postcapillary venules were counted 10 min
after venom injection. The study of the microvascular system of the
transilluminated tissue was accomplished with an optical microscope
(Axio Imager A.1, Carl-Zeiss, Germany) coupled to a camera (IcC 1,
Carl-Zeiss, Germany) using a 10/025 longitudinal distance objective/
numeric aperture and 1.6 optovar.
2.7. Induction of a local inﬂammatory reaction
The induction of an inﬂammatory reaction by the sting venom or
mucus of P. cf. henleiwas assayed according to Lima et al. [33]. Samples
(Mucus near, Mucus far and Venom) of 100 μg of protein in 30 μl of
PBS were injected in the intraplantar region of the right hind footpad.
Animals injected with 30 μl PBS were considered a control group. Two
hours after injection, animals were sacriﬁced, and the right pawswere
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with a glass piston in 200 μl of PBS to reach a 1 ml of cell suspension.
2.8. Cell harvesting and counting
Leukocyte migration was assessed 2 h after Potamotrygon cf. henlei
sting venom, mucus near, mucus far or PBS administration in the
footpad. The samples were immediately centrifuged at 3000 rpm, at
4 °C, for 20 min. The supernatants were stored at −20 °C for future
determinations. The cell pellets were resuspended in 1 ml of PBS+
0.1% BSA for cell counts. Total cell counts were performed in a
hemocytometer and differential leukocyte counts in cytocentrifuge
preparations stained with Wright–Giemsa. Cells were differentially
counted by microscopy, evaluating 300 cells per slide. The results
represent the mean±SEM per millilitre of cell suspension of three
independent experiments.
2.9. Histological assessment of leukocyte inﬂux
Mice injected with 100 μg of P. cf. henlei sting venom, mucus near,
mucus far or PBS were killed 2 h later and footpads were removed,
immediately ﬁxed in 10% buffered formalin. The tissue was processed
and embedded in parafﬁn. Five-micrometer tissue sections were
prepared and stained by the Hematoxilin and Eosin method. All slides
were examined with light microscopy at a magniﬁcation of ×40 (Axio
Imager A1, Carl Zeiss, Germany) calibrated with a reference
micrometer slide. For each group of four mice, four stained footpad
sections from eachmouse were analysed. Positive control of leukocyte
inﬂux was induced in mice by injecting 50 μl of a 0.5% solution of
carrageenan (Type IV Lambda; Sigma-Aldrich) in PBS.
2.10. Quantiﬁcation of cytokines and chemokines
Cytokines and chemokines were measured in the supernatant of
the peritoneal exudate lavage ﬂuid or from macrophage cultures by a
speciﬁc two-site sandwich ELISA, using the BDTM OpteIA ELISA Sets
for Interleukin-1 beta (IL-1β), and Interleukin-6 (IL-6), KC (Chemo-
kine family with homology to human IL-8), and Monocyte chemoat-
tractant protein-1 (MCP-1) according to the manufacturer's
instructions (B&D Pharmingen, Oxford, UK). Binding of biotinylated
monoclonal antibodies was detected using streptavidin–biotinylated
horseradish peroxidase complex and 3,3′,5,5′-tetramethylbenzidine
(B&D Pharmingen, Oxford, UK). Samples were quantiﬁed by compar-
ing standard curves of recombinant mice cytokines and chemokines.
The results were expressed as the arithmetic mean±SEM for
triplicate samples. Detection limits were 7.8 pg/ml for each cytokine
and chemokine.
2.11. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE)
SDS-PAGE was carried out according to Laemmli [37]. Protein
(10 μg) of the mucus near, mucus far and sting venoms were analysed
by SDS-PAGE 4–20% acrylamide gradient under reducing conditions.
Prior to electrophoresis, the samples were mixed 1:1 (v/v) with
sample buffer. The gel was stained with the silver stain method.
2.12. Zymography
Zymography with gelatin gels was performed to visualize
gelatinolytic enzymatic activity in the venoms. After electrophoresis
(SDS-PAGE), gels containing 10% polyacrilamyde and 1 mg/mL gelatin
were washed for 30 min in a buffer containing 50 mM Tris–HCl
(pH 7.5), 5 mM CaCl2 and 2.5% Triton X-100, and incubated overnight
(16 h) in incubation buffer at 37 °C [50 mM Tris–HCl, 5 mM CaCl2
0.02% NaN3, pH 7.6 (all reagents from Sigma-Aldrich)] and 1% TritonX-100. Gels were stainedwith Coomassie blue and destained by acetic
acid in methanol and H2O (1:3:6), both for 60 min. In this method, the
proteolytic activity in gelatin is detected as colourless bands on the
otherwise blue gel after staining with Coomassie blue [38].
2.13. Chromatographic proﬁle of the mucus and venoms
The venoms or mucus were processed in the same way as
previously described. Aliquots of 1 mg of the venoms were dissolved
in 1 mL of deionized water in 0.1% TFA and centrifuged at 5000×g for
20 min (10 °C). The supernatants were applied to a system of
reversed-phase binary HPLC (Äkta basic, Amersham Biosciences —
Sweden) for the sample separation. The venoms were loaded in a ACE
C18 column (5 μ, 4.6×250 mm, ACT-Aberdeen, Scotland) in a two-
solvent system: (A) triﬂuoroacetic acid (TFA)/H2O (1:1000) and (B)
TFA/Acetonitrile (ACN)/H2O (1:900:100). The column was eluted at a
ﬂow rate of 1.0 mL/min with a 10 to 80% gradient of solvent B over
40 min. The HPLC column eluates weremonitored by their absorbance
at 214 nm.
2.14. Antibacterial assay
Pooled venom and mucus (male and female) were dissolved in
deionized water and centrifuged at 5000×g for 20 min (room
temperature). The supernatants were loaded onto solid phase
extraction cartridges Sep-Pak, C18 (Waters Corporation, Taunton,
MA, USA) equilibrated in acidiﬁed water (0.1% triﬂuoroacetic acid). A
single aliquot of 3 mg diluted in 3 mL of 0.1% TFA was loaded and the
elution was performed with 40 and 80% acetonitrile, and was further
concentrated by a vacuum centrifuge. Antimicrobial activity was
monitored by a liquid growth inhibition assay against Micrococcus
luteus A270, Escherichia coli SBS 363 and Candida albicans MDM8, as
described by Bulet et al. [39] and Ehret-Sabatier et al. [40]. Pre inocula
of the strains were prepared in Poor Broth (1.0 g peptone in 100 mL of
H2O containing 86 mM NaCl at pH 7.4; 217 mOsM forM. luteus and E.
coli and 1.2 g potato dextrose in 100 mL of H2O at pH 5.0; 79mOsM for
C. albicans) and incubated at 37 °C with shaking. The absorbance at
595 nm was determined and one aliquot of this solution was taken to
obtain cells in logarithmic growth (A595nm~0.6), and diluted 600
times (A595 nm=0.0001). The venom, mucus and fractions were
dissolved in sterile Milli-Q water, at a ﬁnal volume of 100 μl (10 μl of
the peptide and 90 μl of the inoculum in PB broth). After incubation
for 18 h at 30 °C the inhibition of bacterial growth was determined by
measuring absorbance at 595 nm.
2.15. Statistical analysis
All results were presented as means±SEM of at least four animals
in each group. Differences among data were determined by ne way
analysis of variance (ANOVA) followed by Dunnett's test. Differences
between twomeans were determined using unpaired Student's t-test.
Data were considered signiﬁcant at pb0.05.
3. Results
3.1. Pharmacological activities induced by venom and mucus
Mice were ﬁrst injected with different doses (25, 50 and 100 μg) of
venom ormucus (near and far) from P. cf. henlei andwere analysed for
the presence of nociception, edema induction and increase of vascular
permeability.
The nociceptive response observed after injection of venom and
mucus into the mouse right hind-paw are quite similar in all samples,
with a dose-dependent manner of paw licking during 30 min that
reached its maximum at 100 μg of protein (Fig. 1A). The neurogenic
(0–5 min after venom injection) and inﬂammatory (15–40 min) phases
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inﬂammatory phase of nociception being more intense in all sample
groups tested (Fig. 1B). Groups tested with PBS (control group)
presented no signiﬁcant activity.
The results depicted in Fig. 2A demonstrate that the subplantar
injection of tested doses of the venom and mucus caused substantial
paw edema with signiﬁcant response and similar patterns. Therefore,
comparing groups revealed that the sting venom group presented a
higher increase in footpad thickness persisting up to 5 h after venom
injection (Fig. 2B).
To evaluate the induction of vascular permeability, mice received
intraperitoneal injection of the entire venom, mucus or vehicle (PBS)
as the control. After 120 min, the mice were killed and the dye
exudates were measured. The venom and mucus induced an increase,
dose dependent in vascular permeability (Fig. 3) compared to the
mice that received only the vehicle (PBS). The major difference
between the tested groups was observed in the mucus far group.
To assess the effects of the sting venom and mucus in the
microcirculation, intravital microscopy was employed. This method-
ology allows the direct observation of changes in themicrocirculation,
and it is also a plain and noninvasive approach used for understanding
biological effects [41]. The topical application of 100 μg of mucus and
sting venom induced an increase of cellular recruitment characterized
by the number of leukocyte rolling (Fig. 4). For mucus (near and far)
the cellular recruitment started at 10 min after topical application.
Interestingly for the sting venom, an earlier recruitment was
observed, in the ﬁrst 5 min, after the venom application (Fig. 4
inset), and this proﬁle of recruitment was elevated at least two-fold in
animals compared to the tested groups. Fig. 5A shows the increase in*
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Fig. 1. Estimation of nociception-inducing activity. Samples of 30 μl containing different
doses of venom and mucus (25, 50, and 100 μg of protein) were injected (i.pl.) in the
right footpad of mice. The control group was injected only with sterile PBS. Each animal
was then returned to the observation chamber and the amount of time spent (s) licking
or biting each hind paw was recorded for 30 min (A) or 0–5 and 15–40 min (B) and
taken as the index of nociception. Each bar represents mean±SEM. *pb0.05 compared
with control-group.
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Fig. 2. Determination of edema-inducing activity. (A) Samples of 30 μl containing
different doses of venom andmucus (25, 50, and 100 μg of protein) were injected (i.pl.)
in the right footpad of mice. Local edema was quantiﬁed 2 h after injection. (B) Local
edemawas quantiﬁed in 1/2, 1, 2, 3, 4, and 5 h after injection of 30 μl containing 25 μg of
protein/animal. Mice injected with sterile PBS were considered the control-group. The
results were expressed by the difference between experimental and control footpad
thickness. Each point represents mean±SEM. *pb0.05 compared with control-group.the number of adherent cells at the vascular endothelium induced
after topical application of sting venom only. This activity was more
pronounced after 20 to 30 min of experiment (Fig. 5B). No change in
numbers of adhered cells was observed in the other groups or control
animals receiving PBS.
Leukocyte recruitment to the site of injury after mucus and sting
venom injections were evaluated in mice. Fig. 6 shows the increment
in cell recruitment into footpad tissue of animals receiving all tested
samples (venom and mucus) at 2 h. The cellular recruitment induced
by the sting venom (Fig. 6 inset) was characterized by high
recruitment of neutrophils followed by macrophages, whereas the
mucus (near and far) induced signiﬁcant cellular inﬂux characterized
only by the recruitment of neutrophils in this period.
Knowing that the IL-1β and IL-6 cytokines are important
inﬂammatory mediators recognized for their role in the modulation
of cell recruitment, it was important to evaluate their production after
P. cf. henlei mucus and sting venom injection. Thus, we evaluated the
levels of cytokines in the footpad homogenate after injecting 100 μg of
the samples at 2 h. Compared with the control-group, we observed a
signiﬁcant increase in IL-1β and IL-6 levels for all experimental groups
(Fig. 7A and B).
Additionally, MCP-1 and KC chemokines are critical for the
regulation of monocyte and neutrophil trafﬁcking, respectively.
These molecules were also measured 2 h after sample injection in
the footpad homogenates. As shown in Fig. 7 C, the injection of mucus
and sting venom provoked a higher release of KC, andMCP-1was only
detected in higher levels only for the sting venom group (Fig. 7D).
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venoms
The venom and mucus (Mn and Mf) were partially puriﬁed by
solid-phase extraction and divided into 3 fraction eluates with 0, 40
and 80% acetonitrile. A total of 12 samples (including the crude
venom and mucus) were then tested for antimicrobial activity
against Micrococcus luteus (Gram-positive), Escherichia coli (Gram-
negative) and Candida albicans. Of the samples tested, only the
mucus far and two eluates (Mucus far 40 and 80%) inhibited the
growth of C. albicans. The most potent antibacterial activity was
detected in the Mf 80% ACN eluate.
To determine the eletrophoretical proﬁle, the samples were
submitted to an 8–12% SDS-Page (10 μg of protein/well). SDS-PAGE
analysis of the venoms showed a very similar eletrophoretic proﬁle as
shown in Fig. 8A. The P. cf. henlei venoms showed intense bands with
approximately 70 kDa, around 40 and 50 kDa, and one last band
presented approximately 15 kDa. Analysis of gelatinolytic activity
using 5, 10 and 20 μg of the venoms is presented in Fig. 8B. The
venoms showed a similar gelatin hydrolysis proﬁle with several bands
with enzymatic activity, except for one band at 35 kDa observed only
in the sting venom in all tested concentrations.
The tested samples showed signiﬁcant amounts of enzymatic
activities against gelatin, in which the venom presented two weak
bands at 60 and 18 kDa, and two bands around 30 and 35 kDa. Both
mucus tested presented similar gelatin hydrolysis proﬁles with bands
around 30, 20, 18 and 16 kDa (Fig. 8B).
Despite similar identity of venoms identiﬁed by SDS-PAGE, by
reverse phase chromatography we observed the opposite. Typical UV
chromatograms are shown in Fig. 8C, D and E. Although some
similarities of retention times and relative concentration of certain
components seem to occur, the overall proﬁle is quite distinct. The
heterogeneity of venoms demonstrates and conﬁrms several compo-
nents evenly distributed throughout the proﬁle. We observed that the
general shape and peak distribution between the venoms are unlike,
with at least two peaks being different in each chromatogram. In the
ﬁrst 20 min of HPLC separation, some components apparently are not
shared between the samples as the two higher peaks in the mucus
near sample. However it is worth mentioning that important
components are separated at around 30–40 min retention time.µg
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of the supernatant at 620 nm was measured as an indicator of Evans blue leakage into
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Blue/ml.4. Discussion
Although P. cf. henlei is a Brazilian stingray causing serious human
injuries, little has been reported on its venom. For this reason, in the
present communication a comparative analysis regarding venom and
mucus composition of P. cf. henlei collected in Tocantins, together with
a general biochemical and biological characterization of the samples
of venom and mucus studied are reported. To the best of our
knowledge, there is only a couple of reports dealing with the
experimental toxicity of Potamotrygon stingray venoms [14] and
[17], the characterization of two peptides [29,30] and the presence of
a protein with hyaluronidase activity [42]. The venom of P. cf. henlei,
compared with P. cf. scobina and P. gr. orbignyi is similar regarding
activities such as induction of nociception, edema and leukocyte
recruitment.
Local intense pain and edema in stung areas are common signs in
patients suffering stingray attacks, being especially evident in the legs
and foot region [43]. The edematogenic activity by P. cf. henlei mucus
and sting venom in the footpad of mice reproduced a local
inﬂammatory lesion similar to that described in humans. Studies on
stoneﬁsh, toadﬁsh and stingray ﬁsh venom are known to induce
intense and sustained edematogenic responses in mice [14,33,44,45].
Edematogenic activity is dependent on a synergism between
mediators that increase vascular permeability and those that increase
blood ﬂow [46]. The plasma extravasation and edema formation in
response to venom and mucus strongly suggested the involvement of
vasoactive mediators derived from mast cell granules. Serotonin and
histamine are mediators found in large amounts in mast cells [47].
These biogenic amines released from inﬂammatory cells participate in
the genesis of acute inﬂammatory events and in various stages of the
immune response [48].
Leukocytes are key components in the inﬂammatory response due
to their activities. An increase in leukocyte adhesion is a marker of an
inﬂamed and dysfunctional endothelium [49]. The current study
showed that venom andmucus of P. cf. henlei in mice induce increased
leukocyte rolling, with the venom group followed by a gradual
increase in ﬁrmly adherent cells to the endothelium in intravital
experiments. Meanwhile the ability of the venom and mucus to
develop a nociceptive response was also demonstrated, and the
nociception induced during the inﬂammatory period (15–40 min)
could be associated with the augmented rolling and adhesion of
leukocytes to the endothelium of cremaster mice induced by venom.
The ﬁrst phase of this experiment is characterized by neurogenic pain
caused by direct chemical stimulation of nociceptors and reﬂects
centrally mediated pain. The second phase is characterized by
inﬂammatory pain triggered by a combination of stimuli, including
inﬂammation of the peripheral tissues and mechanisms of central
sensitization [50] and results from the action of inﬂammatory
mediators in peripheral tissues such as prostaglandins, serotonin,
histamine and bradykinin.
The selectin family of adhesion molecules is associated with the
initial phase of leukocyte recruitment characterized by leukocyte
rolling [51]. P-selectin is more critical in the initial rolling and slowing
of recruited leukocytes [52], whereas E-selectin is more important in
leukocyte arrest or the transition from slow rolling to ﬁrm adhesion,
as postulated by Smith et al. [53]. In addition, -1 and -2 integrin
adhesion molecules (VCAM-1, ICAM-1) are critical for ﬁrm attach-
ment of activated leukocytes in the recruitment cascade [51]. Our
results support the hypothesis that the venom of P. cf. henlei would
lead to local release of vasoactive mediators, cytokines, and chemoat-
tractants, up-regulating the expression of important adhesion mole-
cules for leukocyte recruitment.
Neutrophils are recruited rapidly into sites of acute infection and
dominate the initial inﬂux of leukocytes [54]. Later in inﬂammation,
leukocytes of the monocyte/macrophage lineage replace neutrophils
as the predominant leukocyte, suggesting a bimodal recruitment
Fig. 5. Adhered leukocytes in postcapillary venules of cremaster muscle. Adhered leukocytes were observed after application of 100 μg of venom, mucus and sterile saline (20 μl,
control). (A) Representative graph showing leukocyte adhering to endothelium after topical application of samples. Determinations were performed for 30 min after venom
injection and values averaged from three independent experiments. (B) Intravital micrograph of cremaster venule showing adherent leukocytes after samples application.
Photographs were obtained from digitized images on the computer monitor. Each point represents mean±SEM. *pb0.05 compared with the control group of three independent
experiments.
Fig. 4. Number of leukocytes rolling. Representative graph showing leukocyte rolling in postcapillary venules of the mice cremaster muscle after subcutaneous application of 100 μg
of venom, mucus and sterile saline (20 μl, control) at different times. Determinations were performed for 30 min after application and values averaged from three independent
experiments. Inset: Leukocyte rolling after 15 min of sting venom administration (arrow); Photographs were obtained from digitized images on the computer monitor. Each point
represents mean±SEM. *pb0.05 compared with control group of three independent experiments.
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Fig. 6. Effect of P. cf. henlei sting venom and mucus on leukocyte recruitment. Samples
(100 μg in 30 μl of PBS) were injected in the intraplantar region of the right hind footpad.
Animals injected with 30 μl PBS were considered the control group. Six hours after
injection, animals were sacriﬁced and the right paws were amputated, the tissue was
processed for cell count. Inset: Fotomicrograph from the footpadofmice injectedwith P. cf.
henlei sting venom (400X, HE). The results represent the mean±SEM. * pb0.05 of three
independent experiments compared with control-group.
1374 J. Monteiro-dos-Santos et al. / International Immunopharmacology 11 (2011) 1368–1377pattern involving a switch from neutrophils to monocytes. Recruited
neutrophils are thought to mediate this switch by releasing soluble
factors into the early inﬂammatory site that initiate monocyte
recruitment [55,56]. Macrophages play a central role in the inﬂam-
matory response, releasing cytokines that control key events in the
initiation, resolution, and repair processes of inﬂammation (reviewed*
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Fig. 7. Quantiﬁcation of cytokines and chemokines in homogenates of footpad from mice in
injected in the intraplantar region of the right hind footpad. Mice only injected with PBS we
paws were amputated, and homogenised for ELISA cytokine determinations. Each bar reprein [57]). In general, the major chemokine responsible for recruiting
monocytes to inﬂammatory sites is the chemokine MCP-1, and
neutrophils are instrumental in mediating a chemokine switch
promoting monocyte chemoattraction [58]. Interestingly, we showed
here a proﬁle of leukocyte recruitment unique for the venom with a
predominance of neutrophils followed by macrophage inﬂux into
mice footpads, and elevated levels of MCP-1 and KC protein at 2 h.
Proteolytic activity detected in venom compares well with
proteolytic activity in Thallassophryne maculosa, stingrays, Potamo-
trygon cf. scobina and P. gr. orbignyi, and Scatophagus. argus venom
[14,59,60]. Mild proteolytic activity has been observed in bullrout,
Notesthes robusta, venom [61].
In addition, antimicrobial activity was found in the mucus far
sample eluted with 40% and 80% acetonitrile. This indicates that the
hydrophilic and/or high hydrophobic substances are not the potent
antimicrobial compounds in the mucus. A report on the antibacterial
activity of crude mucus extracts from farmed cod pointed out that the
response to the tested bacterial strains varied with individual ﬁsh
[62,63]. Histone H2B and two ribosomal proteins with antibacterial
activity have been isolated from epidermal mucus of Atlantic cod [64].
AMPs were found to be important innate defence components in the
epidermal mucosal layer of Moses sole ﬁsh (Pardachirus marmoratus),
winter ﬂounder (Pleuronectes americanus), catﬁsh (Parasilurus aso-
tus), Atlantic halibut (Hippoglossus hippoglossus), rainbow trout
(Oncorhynchus mykiss), Atlantic cod (Gadus morhua) and Hagﬁsh
(Myxine glutinosa L.) [28,65–67]. The bactericidal activity of ﬁsh
epidermalmucus AMPs has been shown to be retained in the presence
of sodium salt and divalent cations [68,69]. These observations
suggest that ﬁsh epidermal mucus is a good source of novel AMPs
for ﬁsh and human health-related applications.
As presented in the HPLC proﬁles, another conclusion drawn from
this study is that there must be venom variations among the
specimens collected in certain areas. For example, in the studyB
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jected with P. cf. henlei sting venom and mucus. Samples (100 μg in 30 μl of PBS) were
re considered the control group. After 2 and 24 h, animals were sacriﬁced and the right
sents mean±SEM. pb0.05 for triplicate samples compared with the control-group.
Fig. 8. (A) Analysis by SDS-PAGE of venoms using a polyacrylamide gradient gel 4–20% and stained with Silver (A). Lanes: 1) Sting venom; 2) Mucus near; 3) Mucus far. Numbers at
left corresponded to position of Mwmarkers; (B) Gelatin zymography 12% P. cf. henleimucus and sting venoms. Lanes: 1) Sting venom 5 μg; 2) Mucus near 5 μg; 3)Mucus far 5 μg; 4)
Sting venom 10 μg; 5) Mucus near 10 μg; 6) Mucus far 10 μg; 7) Sting venom 20 μg; 8) Mucus near 20 μg; 9) Mucus far 10 μg. Numbers at left correspond to position of Mwmarkers;
Comparison of the preparative reverse phase HPLC proﬁles obtained for the sting venom (C), mucus near (D) and mucus far (E) from P. cf. henlei venom. The amount of protein
injected into the column was 1 mg. The presence of peptides or proteins in the eluate was detected by measuring the UV absorption at 214 nm. Selected peaks (arrows) show the
major differences between the samples. All other experimental details are given in materials and methods section.
1375J. Monteiro-dos-Santos et al. / International Immunopharmacology 11 (2011) 1368–1377realized with P gr. orbignyi collected in the same region, we can notice
the presence of two hydrophilic peaks in the venom chromatogram
not seen in the P. cf. henlei venom proﬁle. These two peaks contain the
bioactive peptides orpotrin and porﬂan [29,30]. Although these
populations of stingrays seem to be very close, the composition and
potency of their venoms is slightly different.
Discoveries of toxins from venoms, especially from aquatic
resources, are racing ahead because of their extremely complex and
unique action on various physiological systems. After all, venoms are
part of an organism's defence and/or predatory mechanisms, whose
speciﬁcity has beenhoned over amillion years of evolution. Venomous
ﬁsh represent a vast source of novel molecules that may prove useful
either as research tools or therapeutic agents, and have been objects ofstudy for several research groups [45,70–72]. The production of toxins
by ﬁsh is an important strategy that guarantees survival in a highly
competitive ecosystem. These animals produce an enormous number
of molecules such as alkaloids, steroids, peptides and proteins with
chemical and pharmacological proprieties differing from those
presented by venoms of terrestrial animals [73].
In conclusion, the present study contributes to the biological study
of venom in mice correlated with local manifestations described in
P. cf. henlei envenomation in humans as well as proteins in the venom
that contribute to potentiating local tissue destruction. The spectrum of
activity in experimental animals resembles those of other ﬁsh venoms
previously studied. This study found that P. cf. henlei mucus and sting
venom is toxic tomice, havingnociceptive, edematogenic andproteolytic
1376 J. Monteiro-dos-Santos et al. / International Immunopharmacology 11 (2011) 1368–1377activity. Our results also indicate that the inﬂammatory cellular inﬂux
observed could be triggered venom and mucus. It could be inferred
from the present study that P. cf. henlei venom possesses a diverse
mixture of peptides, enzymes and pharmacologically active compo-
nents. Though exact relationships of these components in envenom-
ation have not been previously traced, the involvement of proteins
and peptides in envenomation cannot be ruled out. Further studies
are required to isolate and ﬁnd the mechanism of action of these
molecules in the venom and mucus as well as the elucidation of the
mechanisms involved in the inﬂammatory reaction induced by the
venom.
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